<p>This study evaluates the efficiency and biological consequences of base editing of the single base “Z” mutation in the <a href="https://www.ncbi.nlm.nih.gov/gene/?term=5265">SERIPNA1</a> gene responsible for causing misfolding of the alpha-1 antitrypsin protein that leads to the clinical disease “alpha-1 antitrypsin deficiency". Samples on which the editing is performed are patient-derived iPSCs from a single PiZZ patient. The iPSC line is named “PiZZ-1”. To evaluate possible off-target editing, 5 samples underwent whole genome sequencing. These samples include: 1) PiZZ-1 patient iPSCs at passage 34 (“ZZ p34”); 2) PiZZ-1 patient iPSCs at passage 42 (“ZZ p42”); 3) PiZZ-1 patient iPSCs that underwent nucleofection but not base editing at passage 34, and then were passaged until passage 42 (“ZZ nucleofected”); 4) PiZZ-1 patient iPSCs that underwent base editing of a single allele (“MZ”), and analyzed at passage 42; and 5) PiZZ-1 patient iPSCs that underwent base editing of both alleles (“MM”), and analyzed at passage 42.</p>

Base Editing Reduces Misfolded Protein Accumulation and Toxicity in    Alpha-1 Antitrypsin Deficient Patient iPSC-Hepatocytes

alpha 1-Antitrypsin Deficiency study with WGS data on dbGaP (1 participants)

Base Editing Reduces Misfolded Protein Accumulation and Toxicity in Alpha-1 Antitrypsin Deficient Patient iPSC-Hepatocytes

Description

Applying For Access

Summary